Effect of physical training on liver expression of activin A and follistatin in a nonalcoholic fatty liver disease model in rats

Effect of physical training on liver expression of activin A and follistatin in a nonalcoholic fatty liver disease model in rats

Nonalcoholic fatty liver disease (NAFLD) is characterized by fat accumulation in the liver and is associated with obesity and insulin resistance. Activin A is a member of the transforming growth factor beta (TGF)-β superfamily and inhibits hepatocyte growth. Follistatin antagonizes the biological ac...

Full description

Bibliographic Details
Main Authors:	R.N. Silva, P.G. Bueno, L.R.S. Avó, K.O. Nonaka, H.S. Selistre-Araújo, A.M.O. Leal
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2014-09-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	Activin A Follistatin Steatosis Nonalcoholic fatty liver disease Obesity Exercise
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2014000900746&lng=en&tlng=en

Similar Items

Effects of Aerobic Exercise and Resveratrol Supplementation on Plasma Level and Liver Expression of Activin A and Follistatin in a Rats with Nonalcoholic Fatty liver Disease
by: alireza barari, et al.
Published: (2020-03-01)

Tissue absence initiates regeneration through Follistatin-mediated inhibition of Activin signaling
by: Michael A Gaviño, et al.
Published: (2013-09-01)

The activin-follistatin anti-inflammatory cycle is deregulated in synovial fibroblasts
by: Magnus Diller, et al.
Published: (2019-06-01)

Functional studies of pituitary activin/follistatin system in grass carp
by: Fung, Sai-kit, et al.
Published: (2013)

Activin-follistatin system in the ovary of zebrafish, Danio rerio.
Published: (2003)

Prevalence of thyroid disorders and the correlation of thyroid profile with liver enzymes, serum activin-A and follistatin during the treatment of patients with chronic hepatitis C genotype 1 and 4
by: Ahmed Mohammed Ashshi, et al.
Published: (2014-09-01)

Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone
by: Andrea Iskenderian, et al.
Published: (2018-10-01)

Effects of the Activin A–Follistatin System on Myocardial Cell Apoptosis through the Endoplasmic Reticulum Stress Pathway in Heart Failure
by: Miao Liu, et al.
Published: (2017-02-01)

Follistatin-like 3, an activin A binding protein, is involved in early pregnancy loss
by: Yuqing Xu, et al.
Published: (2020-01-01)

A counter gradient of Activin A and follistatin instructs the timing of hair cell differentiation in the murine cochlea
by: Meenakshi Prajapati-DiNubila, et al.
Published: (2019-06-01)

Activin-A up-regulates type I activin receptor mRNA levels in human immortalized extravillous trophoblast cells.
by: Leung Peter CK, et al.
Published: (2003-03-01)

Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer
by: Darcie D. Seachrist, et al.
Published: (2017-06-01)

Roles of intracerebral activin, inhibin, and follistatin in the regulation of Kiss-1 gene expression: Studies using primary cultures of fetal rat neuronal cells
by: Zolzaya Tumurgan, et al.
Published: (2020-09-01)

Cloning and characterization of follistatin in the goldfish, Carassius auratus.
Published: (2003)

Androgen-Influenced Polarization of Activin A-Producing Macrophages Accompanies Post-pyelonephritic Renal Scarring
by: Teri N. Hreha, et al.
Published: (2020-07-01)

Reproductive hormones in breast cancer bone metastasis: The role of inhibins
by: Caroline Wilson
Published: (2016-09-01)

The genetics of nonalcoholic fatty liver disease
by: Christoph H. Österreicher;, et al.
Published: (2007-04-01)

Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosis
by: Rasha AlShaalan, et al.
Published: (2015-01-01)

Prevalence and Clinical Characteristics of Nonalcoholic Liver Disease in Type 2 Diabetes Mellitus Patients: A Crosssectional Study
by: Lakshmi Ravansamudram Hariharan, et al.
Published: (2021-04-01)

The Roles of Activin A and B in Liver Inflammation and Fibrosis
by: Hamang, Matthew J.
Published: (2019)

Grass Carp Follisatin: Molecular Cloning, Functional Characterization, Dopamine D1 Regulation at Pituitary Level, and Implication in Growth Hormone Regulation
by: Roger S. K. Fung, et al.
Published: (2017-08-01)

Prediction of course and progression of nonalcoholic fatty liver disease in patients with obesity and pathology of the biliary tract with the help of mathematical modeling.
by: A. Yu. Filippova, et al.
Published: (2017-12-01)

The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease
by: Mary Barbara, et al.
Published: (2021-09-01)

EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS
by: A. V. Bogolyubova, et al.
Published: (2019-12-01)

5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease
by: Marcin Banaszczak, et al.
Published: (2020-02-01)

Structural and Biochemical Insights into Myostatin Regulation
by: Cash, Jennifer N.
Published: (2011)

Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD)
by: Judith Wylie-Rosett, et al.
Published: (2013-10-01)

Autophagy: a new target for nonalcoholic fatty liver disease therapy
by: Mao YQ, et al.
Published: (2016-03-01)

The Mechanism of Action of Follistatin-like Protein-1 (FSTL-1)
by: V. G. Kukes, et al.
Published: (2019-12-01)

Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
by: Jennifer Gallacher, et al.
Published: (2018-06-01)

Features of Glucose Homeostasis and Blood Lipid Spectrum in Patients with Nonalcoholic Fatty Liver Dis ease Depending on the Obesity Degree
by: Korniichuk I., et al.
Published: (2019-04-01)

Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patient with nonalcoholic fatty liver diseas
by: Stergios A. Polyzos, et al.
Published: (2016-09-01)

Transient Elastography Role in the Diagnosis of Nonalcoholic Fatty Liver Disease
by: Yu.M. Stepanov, et al.
Published: (2016-04-01)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
by: T. E. Promenasheva, et al.
Published: (2014-09-01)

Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease
by: Yingfei Xi, et al.
Published: (2020-01-01)

Nonalcoholic fatty liver disease in normal weight subjects: current concepts and approaches (literature review)
by: Yu.M. Stepanov, et al.
Published: (2020-08-01)

Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver Disease
by: Alice Emma Taliento, et al.
Published: (2019-08-01)

ADEMETHIONINE IN THERAPY OF NON-ALCOHOLIC FATTY LIVER DISEASE
by: A. V. Polukhina, et al.
Published: (2017-11-01)

Therapeutic Effects of Garlic on Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial
by: Soleimani D, et al.
Published: (2020-07-01)

The State of Pancreatobiliary System and Intestinal Microflora in Children with Nonalcoholic Fatty Liver Disease
by: N.Yu. Zavgorodnya, et al.
Published: (2016-11-01)